176 related articles for article (PubMed ID: 9016919)
1. Pharmacological characterization of neuropeptide Y-(2-36) binding to neuropeptide Y Y1 and Y2 receptors.
Schober DA; Gackenheimer SL; Gehlert DR
Eur J Pharmacol; 1996 Dec; 318(2-3):307-13. PubMed ID: 9016919
[TBL] [Abstract][Full Text] [Related]
2. Differential distribution of neuropeptide Y Y1 and Y2 receptors in rat and guinea-pig brains.
Gehlert DR; Gackenheimer SL
Neuroscience; 1997 Jan; 76(1):215-24. PubMed ID: 8971773
[TBL] [Abstract][Full Text] [Related]
3. Quantitative receptor autoradiography demonstrates a differential distribution of neuropeptide-Y Y1 and Y2 receptor subtypes in human and rat brain.
Widdowson PS
Brain Res; 1993 Dec; 631(1):27-38. PubMed ID: 8298993
[TBL] [Abstract][Full Text] [Related]
4. Electroconvulsive stimuli enhance both neuropeptide Y receptor Y1 and Y2 messenger RNA expression and levels of binding in the rat hippocampus.
Madsen TM; Greisen MH; Nielsen SM; Bolwig TG; Mikkelsen JD
Neuroscience; 2000; 98(1):33-9. PubMed ID: 10858609
[TBL] [Abstract][Full Text] [Related]
5. Autoradiographic reevaluation of the binding properties of 125I-[Leu31,Pro34]peptide YY and 125I-peptide YY3-36 to neuropeptide Y receptor subtypes in rat forebrain.
Gobbi M; Mennini T; Vezzani A
J Neurochem; 1999 Apr; 72(4):1663-70. PubMed ID: 10098875
[TBL] [Abstract][Full Text] [Related]
6. Characterization of neuropeptide Y receptor subtypes in the normal human brain, including the hypothalamus.
Jacques D; Dumont Y; Fournier A; Quirion R
Neuroscience; 1997 Jul; 79(1):129-48. PubMed ID: 9178870
[TBL] [Abstract][Full Text] [Related]
7. Identification of multiple neuropeptide Y receptor subtypes in the human frontal cortex.
Statnick MA; Schober DA; Gehlert DR
Eur J Pharmacol; 1997 Aug; 332(3):299-305. PubMed ID: 9300264
[TBL] [Abstract][Full Text] [Related]
8. The neuropeptide Y Y1 receptor selective radioligand, [125I][Leu31,Pro34]peptide YY, is also a high affinity radioligand for human pancreatic polypeptide 1 receptors.
Gehlert DR; Gackenheimer SL; Schober DA; Beavers L; Gadski R; Burnett JP; Mayne N; Lundell I; Larhammar D
Eur J Pharmacol; 1996 Dec; 318(2-3):485-90. PubMed ID: 9016942
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors.
Schober DA; Gackenheimer SL; Heiman ML; Gehlert DR
J Pharmacol Exp Ther; 2000 Apr; 293(1):275-80. PubMed ID: 10734179
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y/peptide YY receptor binding sites in the heart: localization and pharmacological characterization.
Allen CJ; Ghilardi JR; Vigna SR; Mannon PJ; Taylor IL; McVey DC; Maggio JE; Mantyh PW
Neuroscience; 1993 Apr; 53(3):889-98. PubMed ID: 7683778
[TBL] [Abstract][Full Text] [Related]
11. Autoradiographic distribution of [125I]Leu31,Pro34]PYY and [125I]PYY3-36 binding sites in the rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands.
Dumont Y; Fournier A; St-Pierre S; Quirion R
Synapse; 1996 Feb; 22(2):139-58. PubMed ID: 8787130
[TBL] [Abstract][Full Text] [Related]
12. Structural characterization of Y1 and Y2 receptors for neuropeptide Y and peptide YY by affinity cross-linking.
Sheikh SP; Williams JA
J Biol Chem; 1990 May; 265(14):8304-10. PubMed ID: 2159475
[TBL] [Abstract][Full Text] [Related]
13. Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31,Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands.
Dumont Y; Fournier A; St-Pierre S; Quirion R
J Pharmacol Exp Ther; 1995 Feb; 272(2):673-80. PubMed ID: 7853181
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
[TBL] [Abstract][Full Text] [Related]
15. Ligand binding and functional effects of systematic double D-amino acid residue substituted neuropeptide Y analogs on Y1 and Y2 receptor types.
Grundemar L; Kahl U; Callréus T; Langel U; Bienert M; Beyermann M
Regul Pept; 1996 Apr; 62(2-3):131-6. PubMed ID: 8795076
[TBL] [Abstract][Full Text] [Related]
16. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor.
Widdowson PS
Brain Res; 1997 May; 758(1-2):17-25. PubMed ID: 9203528
[TBL] [Abstract][Full Text] [Related]
17. Differential changes in messenger RNA expressions and binding sites of neuropeptide Y Y1, Y2 and Y5 receptors in the hippocampus of an epileptic mutant rat: Noda epileptic rat.
Jinde S; Masui A; Morinobu S; Noda A; Kato N
Neuroscience; 2002; 115(4):1035-45. PubMed ID: 12453477
[TBL] [Abstract][Full Text] [Related]
18. Functional autoradiography of neuropeptide Y Y1 and Y2 receptor subtypes in rat brain using agonist stimulated [35S]GTPgammaS binding.
Shaw JL; Gackenheimer SL; Gehlert DR
J Chem Neuroanat; 2003 Nov; 26(3):179-93. PubMed ID: 14615027
[TBL] [Abstract][Full Text] [Related]
19. Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5).
Dumont Y; Cadieux A; Doods H; Fournier A; Quirion R
Can J Physiol Pharmacol; 2000 Feb; 78(2):116-25. PubMed ID: 10737674
[TBL] [Abstract][Full Text] [Related]
20. Identification of cultured cells selectively expressing Y1-, Y2-, or Y3-type receptors for neuropeptide Y/peptide YY.
Wahlestedt C; Regunathan S; Reis DJ
Life Sci; 1992; 50(4):PL7-12. PubMed ID: 1310131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
